Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

139 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Randomized Trial of Lactin-V to Prevent Recurrence of Bacterial Vaginosis.
Cohen CR, Wierzbicki MR, French AL, Morris S, Newmann S, Reno H, Green L, Miller S, Powell J, Parks T, Hemmerling A. Cohen CR, et al. N Engl J Med. 2020 May 14;382(20):1906-1915. doi: 10.1056/NEJMoa1915254. N Engl J Med. 2020. PMID: 32402161 Free PMC article. Clinical Trial.
Metronidazole treatment rapidly reduces genital inflammation through effects on bacterial vaginosis-associated bacteria rather than lactobacilli.
Armstrong E, Hemmerling A, Miller S, Burke KE, Newmann SJ, Morris SR, Reno H, Huibner S, Kulikova M, Liu R, Crawford ED, Castañeda GR, Nagelkerke N, Coburn B, Cohen CR, Kaul R. Armstrong E, et al. Among authors: morris sr. J Clin Invest. 2022 Mar 15;132(6):e152930. doi: 10.1172/JCI152930. J Clin Invest. 2022. PMID: 35113809 Free PMC article. Clinical Trial.
Sexually transmitted infections among participants in an HIV PrEP adherence trial.
Bristow CC, Hassan A, Moore DJ, Dubé MP, Corado K, Chow K, Ellorin E, Blumenthal J, Morris SR; CCTG Team. Bristow CC, et al. Among authors: morris sr. Int J STD AIDS. 2022 Mar;33(4):397-403. doi: 10.1177/09564624211053428. Epub 2022 Mar 3. Int J STD AIDS. 2022. PMID: 35239448 Clinical Trial.
Sustained effect of LACTIN-V (Lactobacillus crispatus CTV-05) on genital immunology following standard bacterial vaginosis treatment: results from a randomised, placebo-controlled trial.
Armstrong E, Hemmerling A, Miller S, Burke KE, Newmann SJ, Morris SR, Reno H, Huibner S, Kulikova M, Nagelkerke N, Coburn B, Cohen CR, Kaul R. Armstrong E, et al. Among authors: morris sr. Lancet Microbe. 2022 Jun;3(6):e435-e442. doi: 10.1016/S2666-5247(22)00043-X. Epub 2022 Apr 21. Lancet Microbe. 2022. PMID: 35659905 Free PMC article. Clinical Trial.
Randomized Trial of Individualized Texting for Adherence Building (iTAB) Plus Motivational Interviewing for PrEP Adherence in Transgender Individuals: The iM-PrEPT Study.
Morris SR, Jain S, Blumenthal J, Bolan R, Dubé MP, Henderson P, Corado K, Sun S, He F, Chow K, Burke L, Anderson PL, Moore DJ. Morris SR, et al. J Acquir Immune Defic Syndr. 2022 Dec 15;91(5):453-459. doi: 10.1097/QAI.0000000000003091. J Acquir Immune Defic Syndr. 2022. PMID: 36084200 Clinical Trial.
No observed bidirectional effect between tenofovir diphosphate concentrations and gender-affirming hormone concentrations among transgender persons switching from tenofovir disoproxil fumarate/emtricitabine to tenofovir alafenamide/emtricitabine for HIV pre-exposure prophylaxis.
Patel N, Morris S, Burke L, Chow K, Pacheco D, Anderson P, Stancyzk F, Blumenthal J. Patel N, et al. Br J Clin Pharmacol. 2024 Apr 22. doi: 10.1111/bcp.16071. Online ahead of print. Br J Clin Pharmacol. 2024. PMID: 38646796
139 results